You are here: Industry Insights > Mylan

News List

Mylan reports lower than expected earnings pharmaphorum
February 28, 2019
Mylan has reported lower than expected full year earnings and 2019 forecasts, thanks partly to delays in its generic Advair approval and continuing problems at its US manufacturing plant.
Mylan Launches Generic Suboxone Sublingual Film americanpharmaceuticalreview
February 26, 2019
Mylan announced the U.S. launch of Buprenorphine and Naloxone Sublingual Film, 8 mg/2 mg and 12 mg/3 mg, a generic version of Indivior's Suboxone® Sublingual Film....
Biogen faces multibillion-dollar Tecfidera loss if Mylan wins latest patent threat fiercepharma
February 24, 2019
Cash cow Tecfidera has been pumping out blockbuster sales as Biogen plows ahead with pricey Alzheimer's trials and scouts for new pipeline assets. But what if those sales took a big hit early next year, instead of eight years later?
Mylan's 'aggressive' generic Advair discount isn't as big as it looks: analysts fiercepharma
February 24, 2019
If Mylan’s aggressive pricing for its generic Advair product sounds familiar, that’s because it is.
Mylan's generic version of ADVAIR DISKUS for asthma, COPD patients gets FDA approval biospectrumasia
February 02, 2019
The European Medicine Agency has launched a six month consultation on the principles that will form the basis of the electronic product information (ePI)…
Ironwood and Allergan settle Linzess patent litigation with Mylan pharmaceutical-technology
January 07, 2019
Ironwood Pharmaceuticals and Allergan have entered an agreement with Mylan Pharmaceuticals to settle patent litigations over generic versions of Linzess (linaclotide) medicine.....
Ironwood and Allergan Announce Settlement with Mylan Resolving LINZESS® (linaclotide) Patent Litigation pharmafocusasia
January 04, 2019
Ironwood Pharmaceuticals, Inc. and Allergan plc announced today that the companies have reached an agreement with Mylan Pharmaceuticals, Inc. resolving patent litigations brought in.....
European Commission okays Mylan, Biocon’s biosimilar of cancer drug expressbpd
December 20, 2018
Ogivri is indicated for the treatment of patients with HER2 positive early breast cancer, metastatic breast cancer and metastatic gastric cancer
Mylan Announces Launch of Generic Lialda americanpharmaceuticalreview
December 19, 2018
Mylan announced the U.S. launch of Mesalamine Delayed-Release Tablets USP, 1.2 g, a generic version of Shire's Lialda Delayed-Release Tablets......
Mylan announces victory over Sanofi in Lantus patent claims pharmaceutical-technology
December 17, 2018
Generic drug maker Mylan has announced that the US Patent and Trademark Appeal Board (PTAB) invalidated Sanofi’s patent infringement claims over insulin drug Lantus......

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page